0001483426-20-000005.txt : 20200731 0001483426-20-000005.hdr.sgml : 20200731 20200731125502 ACCESSION NUMBER: 0001483426-20-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200731 DATE AS OF CHANGE: 20200731 EFFECTIVENESS DATE: 20200731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MBio Diagnostics, Inc. CENTRAL INDEX KEY: 0001483426 IRS NUMBER: 300593627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-372233 FILM NUMBER: 201064908 BUSINESS ADDRESS: STREET 1: 3122 STERLING CIRCLE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-952-2863 MAIL ADDRESS: STREET 1: 3122 STERLING CIRCLE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: mBio Diagnostics, Inc. DATE OF NAME CHANGE: 20100204 D 1 primary_doc.xml X0708 D LIVE 0001483426 MBio Diagnostics, Inc. 5603 Arapahoe Avenue Suite 1 BOULDER CO COLORADO 80303 303-952-2905 DELAWARE mBio Diagnostics, Inc. Corporation true Christopher Myatt 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Executive Officer Director Andrew Drenick 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Director Robert Silverman 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Director Michael Chang 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Director Judith O'Brien 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Director Other Decline to Disclose 06b false 2020-07-17 false true false 0 11000000 6146350 4853650 Total amount sold includes the conversion of convertible promissory notes in the principal amount of $3,231,350. false 11 0 0 0 false MBio Diagnostics, Inc. /s/ Christopher J. Myatt Christopher J. Myatt CEO, by Tyler Hayden, Attorney-in-Fact 2020-07-31